Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,28 USD | -3,53% | -7,08% | -19,61% |
01/04 | ASPIRA WOMEN'S HEALTH INC. : Cantor Fitzgerald vindt het aandeel niet inspirerend | ZM |
28/03 | Transcript : Aspira Women's Health Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Omzet 2024 * | 10,96 mln. 10,22 mln. | Omzet 2025 * | 19,67 mln. 18,34 mln. | Marktkapitalisatie | 40,49 mln. 37,74 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -17 mln. -15,85 mln. | Nettowinst (verlies) 2025 * | -15 mln. -13,98 mln. | EV/omzet 2024 * | 3,69 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,06 x |
K/w-verhouding 2024 * |
-2,44
x | K/w-verhouding 2025 * |
-3,17
x | Werknemers | 64 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 61,16% |
Recentste transcriptie over Aspira Women's Health Inc.
1 dag | -3,53% | ||
1 week | -7,08% | ||
Lopende maand | +5,81% | ||
1 maand | -7,87% | ||
3 maanden | -23,54% | ||
6 maanden | -34,27% | ||
Lopend jaar | -19,61% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Sandford
CEO | Chief Executive Officer | 54 | 22-02-21 |
Sandra Milligan
PSD | President | - | 01/04 |
Torsten Hombeck
DFI | Director of Finance/CFO | 54 | 15-06-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ellen Vos
BRD | Director/Board Member | 68 | 09-05-23 |
Director/Board Member | 58 | 09-05-23 | |
Jannie Herchuk
CHM | Chairman | 61 | 09-05-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 3,28 | -3,53% | 6 352 |
24-04-24 | 3,4 | +0,29% | 4 508 |
23-04-24 | 3,39 | -3,14% | 7 829 |
22-04-24 | 3,5 | +0,29% | 5 397 |
19-04-24 | 3,49 | -1,13% | 6 952 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-19,61% | 40,49 mln. | |
-20,53% | 10,67 mld. | |
+41,94% | 3,22 mld. | |
-36,56% | 2,09 mld. | |
-18,92% | 2,04 mld. | |
-29,19% | 1,46 mld. | |
+15,73% | 1 mld. | |
-4,37% | 734 mln. | |
-37,00% | 391 mln. | |
-46,73% | 379 mln. |